US Infant Formula Safety Questions Don’t Include Cronobacter National Reportable Disease Listing

FDA submitted four questions for USDA committee's advice on strengthening prevention of cronobactera contaminations such as problem leading to Abbott facility shutdown earlier in 2022 and supply shortage still affecting US. "High mortality rate of infants infected with cronobacter sakazakii should be enough for consumers expect this issue to receive an urgent response,” Stop Foodborne Illness CEO Mitzi Baum tells FDA and USDA.

• Source: Shutterstock

Numerous questions remain unanswered about preventing further problems with cronobacter bacteria contamination in infant formula marketed in the US, but one answer the Food and Drug Administration and food safety advocates suggest is requiring national disease reporting for cronobacter.

More from Supply Chain

More from HBW Insight